Guardant Health (GH) Competitors $57.19 +1.79 (+3.23%) Closing price 04:00 PM EasternExtended Trading$56.92 -0.27 (-0.47%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock GH vs. VCYT, NTRA, HIMS, RDNT, OPCH, SHC, BTSG, WGS, CON, and PRVAShould you be buying Guardant Health stock or one of its competitors? The main competitors of Guardant Health include Veracyte (VCYT), Natera (NTRA), Hims & Hers Health (HIMS), RadNet (RDNT), Option Care Health (OPCH), Sotera Health (SHC), BrightSpring Health Services (BTSG), GeneDx (WGS), Concentra Group Holdings Parent (CON), and Privia Health Group (PRVA). These companies are all part of the "healthcare" industry. Guardant Health vs. Its Competitors Veracyte Natera Hims & Hers Health RadNet Option Care Health Sotera Health BrightSpring Health Services GeneDx Concentra Group Holdings Parent Privia Health Group Veracyte (NASDAQ:VCYT) and Guardant Health (NASDAQ:GH) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment. Do institutionals and insiders hold more shares of VCYT or GH? 92.6% of Guardant Health shares are owned by institutional investors. 1.4% of Veracyte shares are owned by insiders. Comparatively, 6.1% of Guardant Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor VCYT or GH? In the previous week, Guardant Health had 22 more articles in the media than Veracyte. MarketBeat recorded 24 mentions for Guardant Health and 2 mentions for Veracyte. Veracyte's average media sentiment score of 1.40 beat Guardant Health's score of 0.92 indicating that Veracyte is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Veracyte 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardant Health 13 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has higher valuation and earnings, VCYT or GH? Veracyte has higher earnings, but lower revenue than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVeracyte$445.76M5.62$24.14M$0.3396.45Guardant Health$739.02M9.65-$436.37M-$3.35-17.07 Which has more risk & volatility, VCYT or GH? Veracyte has a beta of 2.07, meaning that its stock price is 107% more volatile than the S&P 500. Comparatively, Guardant Health has a beta of 1.46, meaning that its stock price is 46% more volatile than the S&P 500. Is VCYT or GH more profitable? Veracyte has a net margin of 5.50% compared to Guardant Health's net margin of -49.93%. Veracyte's return on equity of 6.07% beat Guardant Health's return on equity.Company Net Margins Return on Equity Return on Assets Veracyte5.50% 6.07% 5.53% Guardant Health -49.93%N/A -28.95% Do analysts recommend VCYT or GH? Veracyte presently has a consensus target price of $40.90, suggesting a potential upside of 28.50%. Guardant Health has a consensus target price of $58.24, suggesting a potential upside of 1.83%. Given Veracyte's higher probable upside, research analysts clearly believe Veracyte is more favorable than Guardant Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Veracyte 1 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.70Guardant Health 0 Sell rating(s) 0 Hold rating(s) 17 Buy rating(s) 1 Strong Buy rating(s) 3.06 SummaryVeracyte beats Guardant Health on 9 of the 17 factors compared between the two stocks. Get Guardant Health News Delivered to You Automatically Sign up to receive the latest news and ratings for GH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GH vs. The Competition Export to ExcelMetricGuardant HealthMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.91B$3.12B$5.75B$10.31BDividend YieldN/A2.37%5.89%4.63%P/E Ratio-17.0721.0376.6626.52Price / Sales9.65408.45492.30109.02Price / CashN/A45.4837.2260.63Price / Book-50.619.5613.946.31Net Income-$436.37M-$53.02M$3.29B$271.37M7 Day Performance1.10%0.37%0.63%2.11%1 Month Performance-2.87%3.93%4.32%6.67%1 Year Performance127.94%8.61%84.13%27.84% Guardant Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GHGuardant Health3.8247 of 5 stars$57.19+3.2%$58.24+1.8%+118.3%$6.91B$739.02M-17.072,021Insider TradeVCYTVeracyte3.7975 of 5 stars$32.46+0.1%$40.90+26.0%-4.0%$2.55B$445.76M98.37790Positive NewsNTRANatera3.4247 of 5 stars$167.39-0.4%$194.00+15.9%+35.0%$22.97B$1.70B-87.644,434Positive NewsHIMSHims & Hers Health2.4391 of 5 stars$49.77+2.8%$38.92-21.8%+211.8%$11.25B$1.48B62.211,637Trending NewsInsider TradeRDNTRadNet3.3446 of 5 stars$71.99+0.8%$76.80+6.7%+12.6%$5.54B$1.83B-359.9311,021Positive NewsOPCHOption Care Health4.8732 of 5 stars$29.59+1.7%$35.75+20.8%-13.2%$4.80B$5.00B23.678,088Positive NewsSHCSotera Health2.7367 of 5 stars$15.91+1.9%$16.00+0.6%-3.6%$4.52B$1.10B198.903,000Positive NewsHigh Trading VolumeBTSGBrightSpring Health Services2.2638 of 5 stars$25.48+5.6%$25.67+0.7%+94.7%$4.51B$12.57B82.2035,000High Trading VolumeWGSGeneDx2.5874 of 5 stars$129.33-2.4%$101.63-21.4%+221.8%$3.72B$362.32M2,586.601,200Positive NewsCONConcentra Group Holdings Parent3.0887 of 5 stars$22.79-1.3%$27.50+20.7%-8.4%$2.92B$1.90B19.1511,250Positive NewsPRVAPrivia Health Group4.4303 of 5 stars$23.59+1.3%$28.58+21.2%+19.4%$2.90B$1.90B214.471,140Positive News Related Companies and Tools Related Companies Veracyte Alternatives Natera Alternatives Hims & Hers Health Alternatives RadNet Alternatives Option Care Health Alternatives Sotera Health Alternatives BrightSpring Health Services Alternatives GeneDx Alternatives Concentra Group Holdings Parent Alternatives Privia Health Group Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:GH) was last updated on 9/17/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardant Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardant Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GH Stock Alerts